Kathryn Kohl joins PSG as Director of Scientific and Clinical Affairs, bringing with her over 25 years of medical device and project development expertise. Ms. Kohl has held several senior level positions in business management, manufacturing, operations and sales team development at BioDX, Scimedx and EUROIMMUN US. She managed business areas ranging from contract manufacturing to technology transfer and regulatory affairs, including overseeing more than 75 medical device FDA submissions. Kathryn’s positions as Production Manager, Vice President of Operations, Executive Vice President and Owner showcase her broad range of leadership skills. In addition, she spearheaded marketing efforts, strategic alliance development, acquisitions and integrations, successfully commercializing a variety of products in diverse regulatory, political and economic environments.
With the addition of Kathryn Kohl, Plasma Services Group further expands our clinical network and project capabilities. With over 1,900 units of serologically defined plasma and serum in inventory, an active and growing donor recruitment program and diverse industry network, PSG prides itself on the ability to find, qualify and supply rare infectious and autoimmune sera to support diagnostic kit development and manufacturing. Kathryn’s new leadership role strengthens its core business offerings to better serve clients.
Click To Download
